by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
The scientific community’s interest in Semax (Semax Heptapeptide) has grown steadily over the past decade. Composed of 7 amino acids, this peptide has demonstrated notable effects in preclinical models related to cognitive enhancement and stroke recovery. Here,...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Among the many peptides under active investigation, Selank stands out for its unique properties and versatile research applications. Originally studied for its effects on BDNF modulation, researchers have since discovered connections to tuftsin analog, cognitive...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
In the ever-expanding landscape of peptide research, PE-22-28 occupies a notable position. This 7 amino acids compound has been the subject of numerous studies investigating its role in TREK-1 inhibitor and antidepressant. This article provides a detailed overview of...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Dihexa, also known as Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide), is a modified hexapeptide peptide that has garnered significant attention in the research community. Studies have explored its potential in memory enhancement, synaptogenesis, and related...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into Semax represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 7 amino acids compound has shown promise in areas ranging from stroke recovery to BDNF increase, making it a subject of considerable...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
The scientific community’s interest in Selank (Selank Heptapeptide) has grown steadily over the past decade. Composed of 7 amino acids, this peptide has demonstrated notable effects in preclinical models related to tuftsin analog and anxiolytic. Here, we present...
